Acasti Pharma  logo
Acasti Pharma ACST

Quarterly report 2025-Q4
added 02-12-2026

report update icon

Acasti Pharma Cash Conversion Cycle 2011-2026 | ACST

Annual Cash Conversion Cycle Acasti Pharma

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- - - 1.97 -3.39 K - - - - 2.18 K 905 765 329 6.74 K -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
6.74 K -3.39 K 1.08 K

Quarterly Cash Conversion Cycle Acasti Pharma

2025-Q4 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- - - - - - - - - - - - - - - - - - - - 718 631 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
718 631 675

Cash Conversion Cycle of other stocks in the Biotechnology industry

Issuer Cash Conversion Cycle Price % 24h Market Cap Country
FSD Pharma FSD Pharma
HUGE
3.11 K - 5743.5 % $ 69.7 M canadaCanada
Happiness Biotech Group Limited Happiness Biotech Group Limited
HAPP
-3.12 K - 1.35 % $ 17.8 M chinaChina
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
205 $ 16.89 -2.37 % $ 789 M usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
186 - -10.17 % $ 12.2 K usaUSA
Compugen Ltd. Compugen Ltd.
CGEN
-82.7 $ 2.85 -5.94 % $ 266 M israelIsrael
I-Mab I-Mab
IMAB
-1.97 K - - $ 866 M chinaChina
Coherus BioSciences Coherus BioSciences
CHRS
149 $ 1.58 -3.37 % $ 185 M usaUSA
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
12.8 - - $ 40.3 B usaUSA
AstraZeneca PLC AstraZeneca PLC
AZN
-58 - - $ 96.9 B britainBritain
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
17 - -1.52 % $ 24.7 M usaUSA
Arcturus Therapeutics Holdings Arcturus Therapeutics Holdings
ARCT
21.2 $ 7.46 -4.73 % $ 204 M israelIsrael
Eton Pharmaceuticals Eton Pharmaceuticals
ETON
115 $ 29.73 -0.77 % $ 800 M usaUSA
Exelixis Exelixis
EXEL
-8.32 $ 50.09 -1.98 % $ 13.6 B usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
82.8 - -18.52 % $ 27.3 M britainBritain
Fortress Biotech Fortress Biotech
FBIO
-74.9 $ 2.47 7.39 % $ 68.9 M usaUSA
Fennec Pharmaceuticals Fennec Pharmaceuticals
FENC
148 $ 9.51 2.92 % $ 272 M usaUSA
AbCellera Biologics AbCellera Biologics
ABCL
173 $ 4.03 -8.52 % $ 1.2 B canadaCanada
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
119 $ 1.57 -1.26 % $ 418 M britainBritain
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
104 - - - russiaRussia
Gilead Sciences Gilead Sciences
GILD
115 $ 129.56 -1.9 % $ 161 B usaUSA
Advaxis Advaxis
ADXS
-143 K - -9.65 % $ 45.9 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
-34.3 K - 5.93 % $ 314 M canadaCanada
Grifols, S.A. Grifols, S.A.
GRFS
0.000171 $ 7.67 -1.6 % $ 5.21 B spainSpain
AIkido Pharma AIkido Pharma
AIKI
-1.92 - 1.93 % $ 17.4 M usaUSA
Enlivex Therapeutics Ltd. Enlivex Therapeutics Ltd.
ENLV
-193 $ 0.72 -1.76 % $ 32.9 M israelIsrael
Esperion Therapeutics Esperion Therapeutics
ESPR
99.7 $ 3.13 0.32 % $ 651 M usaUSA
Aptinyx Aptinyx
APTX
46.9 - -39.0 % $ 4.57 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
-1.55 K - -0.23 % $ 916 M usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
158 $ 21.66 0.42 % $ 2.76 B usaUSA